Biokine: BioLineRx Initiates Phase 1b Trial of Motixafortide in Acute Respiratory Distress Syndrome Secondary to COVID-19 and Other Respiratory Viruses – CBI
Homepage/Press Release/Biokine: BioLineRx Initiates Phase 1b Trial of Motixafortide in Acute Respiratory Distress Syndrome Secondary to COVID-19 and Other Respiratory Viruses
Press Release
Biokine: BioLineRx Initiates Phase 1b Trial of Motixafortide in Acute Respiratory Distress Syndrome Secondary to COVID-19 and Other Respiratory Viruses
